Literature DB >> 28362919

Activation of Nuclear Factor-kappa B in Endothelial Cells of Chronic Subdural Hematoma Outer Membranes.

Koji Osuka1, Yasuo Watanabe2, Nobuteru Usuda3, Masahiro Aoyama1, Reo Kawaguchi1, Mikinobu Takeuchi1, Masakazu Takayasu1.   

Abstract

BACKGROUND: Chronic subdural hematoma (CSDH) is considered an angiogenic and inflammatory disease. Nuclear factor-kappa B (NF-κB) induces the production of inflammatory cytokines and adhesion molecules, which play an essential role in angiogenesis and inflammation. Recently, the double-stranded RNA-activated protein kinase (PKR) was shown to directly interact with NF-κB subunits to influence its transcriptional activity.
OBJECTIVE: To examine the expression of NF-κB signaling pathway components and PKR in CSDH outer membranes.
METHODS: Eight patients whose outer membranes were successfully obtained during trepanation surgery were included in this study. The IκBα, IKKβ, IKKγ, NF-κB, phosphorylated ( p )-NF-κB, and PKR expression levels were examined using western blotting analysis. NF-κB expression was also examined using immunohistochemistry. We investigated whether CSDH fluid could activate NF-κB in cultured endothelial cells in Vitro.
RESULTS: The IκBα, IKKβ, IKKγ, and NF-κB levels were approximately the same. Additionally, p -NF-κB and PKR were detected at similar levels. Immunostaining showed that NF-κB was expressed in the vascular endothelium. p -NF-κB expression in endothelial cells was significantly induced immediately after treatment with CSDH fluid. Furthermore, NF-κB activation was significantly inhibited by treatment with antibodies directed against vascular endothelial growth factor.
CONCLUSION: PKR might activate NF-κB through vascular endothelial growth factor in endothelial cells, which might be associated with endothelial cell proliferation in the CSDH outer membrane. Thus, the NF-κB signaling pathway could play a critical role in CSDH growth.
Copyright © 2016 by the Congress of Neurological Surgeons

Entities:  

Keywords:  Angiogenesis; Chronic subdural hematoma; NF-κB

Mesh:

Substances:

Year:  2017        PMID: 28362919     DOI: 10.1093/neuros/nyw100

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

1.  Expression of high mobility group B1 and toll-like receptor-nuclear factor κB signaling pathway in chronic subdural hematomas.

Authors:  Koji Osuka; Yasuo Watanabe; Nobuteru Usuda; Kenichiro Iwami; Shigeru Miyachi; Masakazu Takayasu
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

2.  Atorvastatin combined with dexamethasone promote hematoma absorption in an optimized rat model of chronic subdural hematoma.

Authors:  Dong Wang; Yueshan Fan; Jun Ma; Chuang Gao; Xuanhui Liu; Zilong Zhao; Huijie Wei; Guili Yang; Jinhao Huang; Rongcai Jiang; Jianning Zhang
Journal:  Aging (Albany NY)       Date:  2021-11-23       Impact factor: 5.682

3.  Serum Levels of MMP-8 and MMP-9 as Markers in Chronic Subdural Hematoma.

Authors:  Gao-Jian Su; Jie Gao; Chu-Wei Wu; Jun-Feng Zou; Di Zhang; Dong-Liang Zhu; Jun Liu; Jie-Hua Zhang; Xian-Jian Huang
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.